---
title: "GoodRx | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 194.01 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285477320.md"
datetime: "2026-05-07T03:14:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285477320.md)
  - [en](https://longbridge.com/en/news/285477320.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285477320.md)
---

# GoodRx | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 194.01 M

Revenue: As of FY2026 Q1, the actual value is USD 194.01 M, beating the estimate of USD 185.41 M.

EPS: As of FY2026 Q1, the actual value is USD 0.

EBIT: As of FY2026 Q1, the actual value is USD 22.38 M.

#### Segment Revenue

-   **Prescription transactions revenue**: Decreased 24% to $113.7 million in Q1 2026, compared to $148.9 million in Q1 2025 .
-   **Subscription revenue**: Increased 16% to $24.4 million in Q1 2026, compared to $21.0 million in Q1 2025 .
-   **Pharma Direct revenue**: Increased 82% to $52.2 million in Q1 2026, compared to $28.6 million in Q1 2025 .
-   **Other revenue**: $3.691 million in Q1 2026, compared to $4.382 million in Q1 2025 .

#### Operational Metrics (GAAP)

-   **Net income**: $1,169 thousand in Q1 2026, compared to $11,052 thousand in Q1 2025 .
-   **Net income margin**: 0.6% in Q1 2026, compared to 5.4% in Q1 2025 .
-   **Operating income**: $14,009 thousand in Q1 2026, compared to $23,380 thousand in Q1 2025 .
-   **Operating income as a percentage of revenue**: 7% in Q1 2026, compared to 12% in Q1 2025 .

#### Operational Metrics (Non-GAAP)

-   **Adjusted Net Income**: $23,049 thousand in Q1 2026, compared to $34,363 thousand in Q1 2025 .
-   **Adjusted Net Income Margin**: 11.9% in Q1 2026, compared to 16.9% in Q1 2025 .
-   **Adjusted EBITDA**: $58,270 thousand in Q1 2026, compared to $69,805 thousand in Q1 2025 .
-   **Adjusted EBITDA Margin**: 30.0% in Q1 2026, compared to 34.4% in Q1 2025 .

#### Operating Costs (GAAP)

-   **Cost of revenue**: $20,156 thousand in Q1 2026, compared to $13,364 thousand in Q1 2025 .
-   **Product development and technology**: $30,177 thousand in Q1 2026, compared to $31,142 thousand in Q1 2025 .
-   **Sales and marketing**: $81,053 thousand in Q1 2026, compared to $84,542 thousand in Q1 2025 .
-   **General and administrative**: $26,819 thousand in Q1 2026, compared to $29,630 thousand in Q1 2025 .
-   **Depreciation and amortization**: $21,792 thousand in Q1 2026, compared to $20,912 thousand in Q1 2025 .

#### Cash Flow and Capital Allocation

-   **Net cash provided by operating activities**: $11,838 thousand in Q1 2026, compared to $9,413 thousand in Q1 2025 .
-   **Cash and cash equivalents**: $235,710 thousand as of March 31, 2026 .
-   **Total outstanding debt**: $487,422 thousand as of March 31, 2026 .
-   **Share Repurchases**: GoodRx Holdings, Inc. repurchased 5.5 million shares of Class A common stock for an aggregate of $12.6 million during Q1 2026 . As of March 31, 2026, the company had $60.2 million of unused authorized share repurchase capacity under its $450.0 million share repurchase program .

#### Key Operating Metrics

-   **Monthly Active Consumers (MACs)**: 5.3 million as of March 31, 2026, compared to 6.4 million as of March 31, 2025 .
-   **Subscription plans**: 717 thousand as of March 31, 2026, compared to 680 thousand as of March 31, 2025 .

#### Outlook / Guidance

GoodRx Holdings, Inc. raised its full year 2026 guidance, now anticipating revenue between $765 million and $785 million, representing a year-over-year change of -4% to -1% compared to $796.9 million in FY 2025 . Adjusted EBITDA for full year 2026 is expected to be greater than $235 million .

### Related Stocks

- [GDRX.US](https://longbridge.com/en/quote/GDRX.US.md)

## Related News & Research

- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [FRONTERA ANNOUNCES FIRST QUARTER 2026 RESULTS | FECCF Stock News](https://longbridge.com/en/news/286507909.md)
- [Guardian Capital Announces May 2026 Cash Distributions for Guardian Capital ETFs](https://longbridge.com/en/news/286857337.md)
- [Correction: NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET | NXXT Stock News](https://longbridge.com/en/news/286673001.md)